NASDAQ: SRPT
Sarepta Therapeutics Inc Earnings Dates, Reports, Calls

Sarepta Therapeutics earnings were -$271.5M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest SRPT earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$179.9M, down 191.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SRPT reported annual earnings of $235.2M, with -143.9% growth. The next SRPT earnings date is Mar 3, 2026.

SRPT earnings history

Current Revenue
$2.4B
Current Earnings
-$271.5M
Current Profit Margin
-11.2%

SRPT Return on Equity

Current Company
-20.3%
Current Industry
-21.2%
Current Market
35.1%
SRPT's Return on Equity (-20.3%)... subscribe to Premium to read more.
High Return on Equity Performance

SRPT Return on Assets

Current Company
-7.4%
Current Industry
-8.8%
SRPT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SRPT announces earnings.

SRPT Return on Capital Employed

Current Company
-9.81%
Current Industry
-3.5%
SRPT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SRPT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SRPT-$187.26M-$271.51MN/A-$2.72
AAPGN/A-$161.45MN/A-$2.02
HRMY$269.64M$185.68M+14.49%$3.23
WVE-$113.20M-$121.95MN/A-$0.65
MAZE-$120.73M-$101.46MN/A-$4.65

SRPT earnings dates

Next earnings date
Mar 3, 2026

Sarepta Therapeutics Earnings Reports & History FAQ

What were Sarepta Therapeutics's earnings last quarter?

On SRPT's earnings call on Invalid Date, Sarepta Therapeutics (NASDAQ: SRPT) reported Q3 2025 earnings per share (EPS) of -$1.80, up 614.29% year over year. Total SRPT earnings for the quarter were -$179.95 million. In the same quarter last year, Sarepta Therapeutics's earnings per share (EPS) was $0.35.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.

When does Sarepta Therapeutics report earnings?

The next SRPT earnings call is Invalid Date. Add SRPT to your watchlist to be reminded of Sarepta Therapeutics's next earnings date.

Is Sarepta Therapeutics profitable or losing money?

As of the last Sarepta Therapeutics earnings report, Sarepta Therapeutics is currently losing money. Sarepta Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$271.51 million, a 322.84% decrease year over year.

What was SRPT's earnings growth in the past year?

As of Sarepta Therapeutics's earnings date in Invalid Date, Sarepta Therapeutics's earnings has grown year over year. SRPT earnings in the past year totalled -$271.51 million.

What are Sarepta Therapeutics's earnings expectations?

The current EPS estimate for Sarepta Therapeutics's earnings report in Invalid Date is -$1.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.